CA2878481A1 - Method for preparing substituted triazolopyridines - Google Patents
Method for preparing substituted triazolopyridines Download PDFInfo
- Publication number
- CA2878481A1 CA2878481A1 CA2878481A CA2878481A CA2878481A1 CA 2878481 A1 CA2878481 A1 CA 2878481A1 CA 2878481 A CA2878481 A CA 2878481A CA 2878481 A CA2878481 A CA 2878481A CA 2878481 A1 CA2878481 A1 CA 2878481A1
- Authority
- CA
- Canada
- Prior art keywords
- amino
- phenyl
- pyridin
- triazolo
- fluorophenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 0 CCN(CC)C(c(cc1)cc(OCC(F)(F)F)c1Nc1n[n](cc(*)cc2)c2n1)=O Chemical compound CCN(CC)C(c(cc1)cc(OCC(F)(F)F)c1Nc1n[n](cc(*)cc2)c2n1)=O 0.000 description 24
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12175640.7 | 2012-07-10 | ||
| EP12175640 | 2012-07-10 | ||
| EP12185590 | 2012-09-24 | ||
| EP12185590.2 | 2012-09-24 | ||
| EP13170585.7 | 2013-06-05 | ||
| EP13170585 | 2013-06-05 | ||
| PCT/EP2013/064017 WO2014009219A1 (en) | 2012-07-10 | 2013-07-03 | Method for preparing substituted triazolopyridines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2878481A1 true CA2878481A1 (en) | 2014-01-16 |
Family
ID=48793197
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2878481A Abandoned CA2878481A1 (en) | 2012-07-10 | 2013-07-03 | Method for preparing substituted triazolopyridines |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US9388177B2 (enEXAMPLES) |
| EP (1) | EP2872506A1 (enEXAMPLES) |
| JP (1) | JP6238979B2 (enEXAMPLES) |
| KR (1) | KR20150040845A (enEXAMPLES) |
| CN (1) | CN104603136B (enEXAMPLES) |
| AP (1) | AP3778A (enEXAMPLES) |
| AU (1) | AU2013289381A1 (enEXAMPLES) |
| BR (1) | BR112015000308A2 (enEXAMPLES) |
| CA (1) | CA2878481A1 (enEXAMPLES) |
| CL (1) | CL2015000038A1 (enEXAMPLES) |
| CO (1) | CO7160002A2 (enEXAMPLES) |
| CR (1) | CR20150006A (enEXAMPLES) |
| DO (1) | DOP2015000007A (enEXAMPLES) |
| EA (1) | EA027544B1 (enEXAMPLES) |
| HK (1) | HK1206731A1 (enEXAMPLES) |
| IL (1) | IL236265A (enEXAMPLES) |
| IN (1) | IN2015DN00085A (enEXAMPLES) |
| MX (1) | MX2015000348A (enEXAMPLES) |
| NZ (1) | NZ703020A (enEXAMPLES) |
| PE (1) | PE20150354A1 (enEXAMPLES) |
| PH (1) | PH12015500061A1 (enEXAMPLES) |
| SG (1) | SG11201408419QA (enEXAMPLES) |
| TN (1) | TN2015000008A1 (enEXAMPLES) |
| WO (1) | WO2014009219A1 (enEXAMPLES) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2914521A1 (en) * | 2013-06-07 | 2014-12-11 | Bayer Pharma Aktiengesellschaft | Substituted triazolopyridines having activity as mps-1 inhibitors |
| AU2014280354A1 (en) | 2013-06-11 | 2015-12-03 | Bayer Pharma Aktiengesellschaft | Combinations for the treatment of cancer comprising a Mps-1 kinase inhibitor and a mitotic inhibitor |
| HRP20170717T1 (hr) * | 2013-06-11 | 2017-07-28 | Bayer Pharma Aktiengesellschaft | Derivati predlijeka supstituiranih triazolopiridina |
| FI3283642T3 (fi) | 2015-04-17 | 2024-01-11 | Crossfire Oncology Holding B V | Prognostisia biomarkkereita ttk-inhibiittorikemoterapiaan |
| TW201800408A (zh) | 2016-06-15 | 2018-01-01 | 拜耳製藥公司 | Mps-1抑制劑 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1438973A4 (en) * | 2001-10-05 | 2005-07-13 | Ono Pharmaceutical Co | MEANS FOR THE TREATMENT OF STRESS-RELATED DISEASES WITH MITOCHONDRIENE BENZODIAZEPINE RECEPTOR ANTAGONISTS |
| WO2005110410A2 (en) * | 2004-05-14 | 2005-11-24 | Abbott Laboratories | Kinase inhibitors as therapeutic agents |
| UA89503C2 (uk) * | 2004-09-13 | 2010-02-10 | Х. Луннбек А/С | Заміщені похідні аніліну |
| JP2008515874A (ja) * | 2004-10-07 | 2008-05-15 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | 抗菌薬 |
| US20060194823A1 (en) * | 2004-12-22 | 2006-08-31 | Georg Kettschau | Sulfonamido-macrocycles as Tie2 inhibitors and the salts thereof, a pharmaceutical composition comprising these compounds, the method of preparing and the use thereof |
| JP2009539840A (ja) * | 2006-06-06 | 2009-11-19 | シェーリング コーポレイション | プロテインキナーゼ阻害剤としてのイミダゾピラジン |
| EP1870416A1 (en) * | 2006-06-21 | 2007-12-26 | Bayer Schering Pharma Aktiengesellschaft | Sulphonamido-macrocycles as tie2 inhibitors |
| EP2057158B8 (en) | 2006-08-30 | 2015-09-30 | Cellzome Limited | Triazole derivatives as kinase inhibitors |
| JO3598B1 (ar) * | 2006-10-10 | 2020-07-05 | Infinity Discovery Inc | الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني |
| CA2693232A1 (en) | 2007-07-18 | 2009-01-22 | Novartis Ag | Bicyclic heteroaryl compounds and their use as kinase inhibitors |
| KR20100057650A (ko) | 2007-08-23 | 2010-05-31 | 아스트라제네카 아베 | 증식성 질환의 치료를 위한 ｔｔｋ／ｍｐｓ１의 억제제로서 ２-아닐리노푸린-８-온 |
| JP2010536917A (ja) | 2007-08-31 | 2010-12-02 | メルク セローノ ソシエテ アノニム | トリアゾロピリジン化合物と、ａｓｋ阻害剤としてのその化合物の利用法 |
| GB0719803D0 (en) | 2007-10-10 | 2007-11-21 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
| GB0724342D0 (en) * | 2007-12-13 | 2008-01-30 | Prolysis Ltd | Anitbacterial compositions |
| US8530689B2 (en) * | 2008-05-05 | 2013-09-10 | The Trustees Of The University Of Pennsylvania | Processes for the preparation of biphenyl compounds |
| WO2009155527A2 (en) * | 2008-06-19 | 2009-12-23 | Progenics Pharmaceuticals, Inc. | Phosphatidylinositol 3 kinase inhibitors |
| JP2012517971A (ja) | 2009-02-13 | 2012-08-09 | フォーヴィア・ファーマシューティカルズ | キナーゼ阻害薬としての［１，２，４］トリアゾロ［１，５−ａ］ピリジン類 |
| CA2760077A1 (en) | 2009-04-29 | 2010-11-04 | Marcus Koppitz | Substituted imidazoquinoxalines |
| AU2010254806C1 (en) * | 2009-06-05 | 2016-07-07 | Cephalon, Inc. | Preparation and uses of 1,2,4-triazolo [1,5a] pyridine derivatives |
| WO2010141360A1 (en) * | 2009-06-05 | 2010-12-09 | Merck Sharp & Dohme Corp. | Biaryl benzotriazole derivatives |
| CA2772790C (en) | 2009-09-04 | 2017-06-27 | Benjamin Bader | Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors |
| EP2343295A1 (en) * | 2009-11-30 | 2011-07-13 | Bayer Schering Pharma AG | Triazolopyridine derivates |
| EP2343297A1 (en) * | 2009-11-30 | 2011-07-13 | Bayer Schering Pharma AG | Triazolopyridines |
| EP2343294A1 (en) * | 2009-11-30 | 2011-07-13 | Bayer Schering Pharma AG | Substituted triazolopyridines |
| UY33452A (es) * | 2010-06-16 | 2012-01-31 | Bayer Schering Pharma Ag | Triazolopiridinas sustituidas |
| WO2012044567A2 (en) * | 2010-09-30 | 2012-04-05 | Merck Sharp & Dohme Corp. | Imidazole derivatives |
| SG194003A1 (en) * | 2011-04-21 | 2013-11-29 | Bayer Ip Gmbh | Triazolopyridines |
| WO2012160029A1 (en) * | 2011-05-23 | 2012-11-29 | Bayer Intellectual Property Gmbh | Substituted triazolopyridines |
| UA112096C2 (uk) * | 2011-12-12 | 2016-07-25 | Байєр Інтеллектуал Проперті Гмбх | Заміщені триазолопіридини та їх застосування як інгібіторів ttk |
-
2013
- 2013-07-03 US US14/414,164 patent/US9388177B2/en not_active Expired - Fee Related
- 2013-07-03 EP EP13737181.1A patent/EP2872506A1/en not_active Withdrawn
- 2013-07-03 IN IN85DEN2015 patent/IN2015DN00085A/en unknown
- 2013-07-03 AU AU2013289381A patent/AU2013289381A1/en not_active Abandoned
- 2013-07-03 WO PCT/EP2013/064017 patent/WO2014009219A1/en active Application Filing
- 2013-07-03 SG SG11201408419QA patent/SG11201408419QA/en unknown
- 2013-07-03 NZ NZ703020A patent/NZ703020A/en not_active IP Right Cessation
- 2013-07-03 CN CN201380045913.9A patent/CN104603136B/zh not_active Expired - Fee Related
- 2013-07-03 JP JP2015520907A patent/JP6238979B2/ja not_active Expired - Fee Related
- 2013-07-03 CA CA2878481A patent/CA2878481A1/en not_active Abandoned
- 2013-07-03 MX MX2015000348A patent/MX2015000348A/es unknown
- 2013-07-03 BR BR112015000308A patent/BR112015000308A2/pt not_active IP Right Cessation
- 2013-07-03 KR KR20157000338A patent/KR20150040845A/ko not_active Withdrawn
- 2013-07-03 AP AP2014008177A patent/AP3778A/en active
- 2013-07-03 HK HK15107242.4A patent/HK1206731A1/xx unknown
- 2013-07-03 EA EA201590116A patent/EA027544B1/ru not_active IP Right Cessation
- 2013-07-03 PE PE2015000017A patent/PE20150354A1/es not_active Application Discontinuation
-
2014
- 2014-12-15 IL IL236265A patent/IL236265A/en not_active IP Right Cessation
-
2015
- 2015-01-07 TN TNP2015000008A patent/TN2015000008A1/fr unknown
- 2015-01-08 CL CL2015000038A patent/CL2015000038A1/es unknown
- 2015-01-09 DO DO2015000007A patent/DOP2015000007A/es unknown
- 2015-01-09 CR CR20150006A patent/CR20150006A/es unknown
- 2015-01-09 PH PH12015500061A patent/PH12015500061A1/en unknown
- 2015-01-09 CO CO15004251A patent/CO7160002A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CO7160002A2 (es) | 2015-01-15 |
| PH12015500061A1 (en) | 2015-03-02 |
| MX2015000348A (es) | 2015-04-14 |
| PE20150354A1 (es) | 2015-03-21 |
| CL2015000038A1 (es) | 2015-03-13 |
| JP2015523372A (ja) | 2015-08-13 |
| EP2872506A1 (en) | 2015-05-20 |
| EA201590116A1 (ru) | 2015-07-30 |
| EA027544B1 (ru) | 2017-08-31 |
| CN104603136A (zh) | 2015-05-06 |
| WO2014009219A1 (en) | 2014-01-16 |
| AP3778A (en) | 2016-08-31 |
| TN2015000008A1 (en) | 2016-06-29 |
| HK1206731A1 (en) | 2016-01-15 |
| CR20150006A (es) | 2015-02-16 |
| US20150148542A1 (en) | 2015-05-28 |
| CN104603136B (zh) | 2017-06-27 |
| NZ703020A (en) | 2017-08-25 |
| AP2014008177A0 (en) | 2014-12-31 |
| JP6238979B2 (ja) | 2017-11-29 |
| SG11201408419QA (en) | 2015-01-29 |
| AU2013289381A1 (en) | 2015-01-22 |
| KR20150040845A (ko) | 2015-04-15 |
| DOP2015000007A (es) | 2015-02-15 |
| IL236265A (en) | 2017-07-31 |
| IN2015DN00085A (enEXAMPLES) | 2015-05-29 |
| BR112015000308A2 (pt) | 2017-06-27 |
| IL236265A0 (en) | 2015-02-26 |
| US9388177B2 (en) | 2016-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI765908B (zh) | 苯並咪唑類化合物激酶抑制劑及其製備方法和應用 | |
| JP5769199B2 (ja) | ピラゾロピリミジンｊａｋ阻害剤化合物と方法 | |
| JP6564406B2 (ja) | カゼインキナーゼ１デルタ／イプシロン阻害剤としてのイミダゾ−ピリダジン誘導体 | |
| JP2019521996A (ja) | キナーゼ阻害剤としてのｎ−（置換フェニル）−スルホンアミド誘導体 | |
| BR112014029708B1 (pt) | Composto de pirrolo[2,1-f][1,2,4]triazina e método de preparação de compostos de pirrolo[2,1-f][1,2,4]triazina | |
| TWI628180B (zh) | 作為ＰＩ３Ｋ抑制劑的吡啶并［１，２－ａ］嘧啶酮類似物 | |
| KR20190058678A (ko) | c-MET 억제제로서의 피리돈계 화합물 | |
| JP2023145548A (ja) | Ｃｄ７３阻害剤、その製造方法と応用 | |
| CA2878481A1 (en) | Method for preparing substituted triazolopyridines | |
| CA2914668A1 (en) | Novel compounds for the treatment of cancer | |
| WO2023036156A1 (zh) | Dna-pk选择性抑制剂及其制备方法和用途 | |
| TW201900649A (zh) | 一種氮雜芳基衍生物、其製備方法和在藥學上的應用 | |
| CN112912142B (zh) | 作为腺苷受体拮抗剂的5-氮杂吲唑衍生物 | |
| CN116023368A (zh) | Crbn免疫调节剂 | |
| CA2914521A1 (en) | Substituted triazolopyridines having activity as mps-1 inhibitors | |
| CA2914745A1 (en) | Prodrug derivatives of substituted triazolopyridines | |
| EP3004092B1 (en) | Substituted triazolopyridines | |
| BR112019010617A2 (pt) | derivados de oxoisoquinolina | |
| HK1222652B (en) | Substituted triazolopyridines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20190703 |